Protalix BioTherapeutics Inc. (PLX): Nilai Total Aset Perusahaan

The daily price chart for Protalix BioTherapeutics (PLX) on the GURU.Markets platform shows total assets at 94.42. Protalix BioTherapeutics utilizes an innovative protein synthesis method in plant cells, which reduces costs and eliminates viral threats. The distribution of the finished enzyme is fully entrusted to a global partner, excluding merger deals, while drug development and delivery rely on external contractors and logistics outsourcing.

Investors utilize fundamental metrics to assess the intrinsic value of a business during periods of market volatility. This indicator reflects the company's total resource volume, calculated inversely via return on assets (ROA) to determine the real cost of capital. Total asset dynamics allow for tracking the efficiency of asset management amid contracting multiples. For Protalix BioTherapeutics (PLX), this is critical: a high dependence on a single drug is offset by a strategic partnership that supports the liquidity of the base.